🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

After one conference ends, another begins! 🎉 #EANO2025 will take place in beautiful Prague🇨🇿 from October 16-19, 2025. Join us to deepen your #NeuroOncology expertise, connect with experts, and share your work with the community. See you in #Prague! eano.eu/eano2025/ #btsm

The IBTA e-News Roundup for November/December 2024 - mailchi.mp/theibta/rculor…

We're excited to have this study on global brain tumour patient advocacy published in Neuro-Oncology Practice #braintumour #patientadvocacy #patientrights academic.oup.com/nop/advance-ar…

🎗️ Today is #WorldCancerDay – a reminder of the ongoing fight against cancer and the need for research, collaboration & innovation in all types, including #NeuroOncology. At #EANO, we’re dedicated to advancing science & patient care. Together, we can make a difference! 💙

Today is World Cancer Day! 🗓️ In the lead up to #RareDiseaseDay 2025, help us to spread awareness about the unique challenges facing the 5.1 million people who are living with a rare cancer in Europe! ➡️ Learn more: go.eurordis.org/RareCancers

After years of dedicated research, we are excited to officially launch the results of SISAQOL-IMI! 🔬 This milestone marks a significant step toward improving patient-centred research and ensuring high-quality PRO data in clinical studies. Subscribe: sisaqol-imi.org

On World Cancer Day, we highlight the connection between cancer and rare diseases. By raising awareness, let’s fight for higher awareness, wider research and better access to healthcare and treatment so that those with rare cancers can live with better support and care.

Visit our website gliomaregistry.org for details in both English and Spanish and to learn about low grade glioma in general Low Grade Glioma Registry American Brain Tumor Association National Brain Tumor Society Salud America! IBTA Yale School of Public Health

Another great article by Alex Landry Farshad Nassiri gelareh-zadeh has just been released in SNO - this one exploring the relevance of group-specific #metabolite profiles of #meningioma. buff.ly/4hEKVz5

The #EUCancerPlan has been a success for member states, yet so much remains to be done. 👈 Inequalities in reach and accessibility of cancer care persist. The solution: concrete, data-driven insights to drive robust policy action. 📈 The #EuropeanCancerPulse provides vital

🚀 We are proud to announce that IMI_SISAQOL final recommendations are here! 🎗️This global initiative, co-led by EORTC & Boehringer Ingelheim, sets new standards for analysing patient-reported outcomes in cancer trials. Learn more: eortc.org/blog/2025/02/0… #CancerResearch #QualityofLife

The IBTA e-News Roundup for January/February 2025 - mailchi.mp/theibta/rculor…

The IBTA e-News Roundup for January/February 2025 - mailchi.mp/theibta/rculor…

There is no cure for brain cancer. More research is desperately needed #RareDiseaseDay2025

The GLIORESOLVE project was featured in the 2024/2025 World Edition of the Brain Tumour Magazine, published by the IBTA You can read the full publication here issuu.com/ibta-org/docs/… and our article is on Pg 23!

Our thoughts are with the loved ones of Dr Stu Farrimond, who has sadly passed away. We are so grateful for everything he did to raise awareness of this cruel disease & fight for better outcomes for those affected. IBTA #BrainTumourResearch #TogetherWeWillFindACure

Could electric fields supercharge immune attack on the deadliest form of brain cancer? news.keckmedicine.org/could-electric…

The IBTA e-News Roundup for May 2025 - mailchi.mp/theibta/may-20…

Machine learning can improve detection of brain cancer from blood source.washu.edu/2025/06/machin…